SCHEMBL5265250

SCHEMBL5265250

OC1Cc2c(OCc3ccccc3)cc(OCc3ccccc3)c(Br)c2OC1c1ccc(OCc2ccccc2)c(OCc2ccccc2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.47
▸ CYP3A4 P08684 2/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ THRB P10828 1/20 0.47
▸ PDE4A P27815 1/20 0.39
▸ PDE4B Q07343 1/20 0.39
▸ PDE4C Q08493 1/20 0.39
▸ PDE4D Q08499 1/20 0.39
▸ SLC6A4 P31645 1/20 0.38
▸ APP P05067 3/20 0.37
▸ PRMT5 O14744 1/20 0.35
▸ HIF1A Q16665 1/20 0.35
▸ BACE1 P56817 4/20 0.34
▸ KDM4E B2RXH2 3/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ GAA P10253 2/20 0.34
▸ PKM P14618 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6670685 0.88 CYP3A4 (0.41) MAPTCYP3A4MAPK1THRBPDE4A
SCHEMBL5268319 0.86 PDE4A (0.38) MAPTCYP3A4MAPK1THRBPDE4A
SCHEMBL9104116 0.86 CYP3A4 (0.46) MAPTCYP3A4MAPK1THRBPDE4A
SCHEMBL9103638 0.86 CYP3A4 (0.46) MAPTCYP3A4MAPK1THRBPDE4A
SCHEMBL6671389 0.83 BACE1 (0.40) MAPTCYP3A4MAPK1THRBPDE4A
SCHEMBL5264345 0.81 PDE4A (0.37) MAPTCYP3A4MAPK1THRBPDE4A
SCHEMBL5620025 0.80 SIRT1 (0.40) MAPTCYP3A4MAPK1THRBPDE4A
SCHEMBL24983638 0.80 CYP3A4 (0.50) MAPTCYP3A4MAPK1APPHIF1A
SCHEMBL13507373 0.80 CYP3A4 (0.50) MAPTCYP3A4MAPK1APPHIF1A
SCHEMBL13507688 0.80 CYP3A4 (0.50) MAPTCYP3A4MAPK1APPHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070276147-A1 Synthesis of Oligomeric Epicatechin- and Catechin-Derived Procyanidins KOZIKOWSKI ALAN P 2007-11-29 — — US claimed
US-6849746-B2 Synthetic methods for polyphenols MARS, INC. (US) 2005-02-01 — — US claimed
JP-2004508362-A — — 2004-03-18 — — JP claimed
EP-1317437-A2 SYNTHESIS OF 4-ALPHA-ARYLEPICATECHINS Mars Incorporated (US) 2003-06-11 — — EP claimed
US-20030100775-A1 Synthesis of 4alpha-arylepicatechins MARS INCORPORATED 2003-05-29 — — US claimed
WO-2002020506-A2 SYNTHESIS OF 4α-ARYLEPICATECHINS MARS, INCORPORATED (US) 2002-03-14 — — WO claimed
EP-1317437-B1 SYNTHESIS OF 4-ALPHA-ARYLEPICATECHINS MARS INC (US) 2007-10-03 — — EP disclosed
US-7268240-B2 Synthetic methods for polyphenols MARS, INC. 2007-09-11 — — US disclosed
US-20070197804-A1 Synthesis of 4alpha-arylepicatechins MARS, INCORPORATED 2007-08-23 — — US disclosed
US-7126014-B2 Synthesis of epecatechin-4α, 8-epicatechin and -catechin dimers and derivatives thereof MARS, INC. 2006-10-24 — — US disclosed
US-6849746-B2 Synthetic methods for polyphenols MARS, INC. (US) 2005-02-01 — — US disclosed
US-20050014958-A1 Synthesis of 4alpha-arylepicatechins MARS, INCORPORATED 2005-01-20 — — US disclosed
US-20040235941-A1 Dimer digallate compositions MARS, INCORPORATED 2004-11-25 — — US disclosed
WO-2002020506-A2 SYNTHESIS OF 4α-ARYLEPICATECHINS MARS, INCORPORATED (US) 2002-03-14 — — WO disclosed
EP-1169304-A1 8-8, 6-6 AND 6-8 CATECHIN AND EPICATECHIN DIMERS AND METHODS FOR THEIR PREPARATION Mars Incorporated (US) 2002-01-09 — — EP disclosed
US-6207842-B1 FROM EPICATECHIN MARS INCORPORATED 2001-03-27 — — US disclosed
US-6156912-A 88, 66, and 68 catechin and epicatechin dimers and methods for their preparation MARS, INCORPORATED (US) 2000-12-05 — — US disclosed
WO-2000061547-A1 8-8, 6-6 AND 6-8 CATECHIN AND EPICATECHIN DIMERS AND METHODS FOR THEIR PREPARATION MARS, INCORPORATED (US) 2000-10-19 — — WO disclosed
EP-1027345-A1 SYNTHETIC METHODS FOR POLYPHENOLS Mars Incorporated (US) 2000-08-16 — — EP disclosed
WO-1999019319-A1 SYNTHETIC METHODS FOR POLYPHENOLS MARS INCORPORATED (US) 1999-04-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030100775-A1 Synthesis of 4alpha-arylepicatechins FABP4, TEAD4, FABP7 MAPT 2148/4885CYP3A4 300/4885MAPK1 2923/4885
US-20050014958-A1 Synthesis of 4alpha-arylepicatechins FABP7, FABP4, TEAD4 MAPT 1948/4885CYP3A4 463/4885MAPK1 2997/4885
US-20040235941-A1 Dimer digallate compositions NOD2, GID4, GPX4 MAPT 1853/4885CYP3A4 304/4885MAPK1 2879/4885
US-20070197804-A1 Synthesis of 4alpha-arylepicatechins FABP7, FABP4, TEAD4 MAPT 1948/4885CYP3A4 463/4885MAPK1 2997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback